Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 9, 2020
Molecular hydrogen: A potential radioprotective agentQiongge Hu, Yunxiang Zhou, Shijie Wu, et al.Medicine|June 16, 2023
A prognostic signature associated with cell senescence predicts survival outcomes and strongly associates with immunotherapy and chemotherapy response in breast cancerTao Pan, Zhengfang Hu, Dongyan Xu, et al.Breast Cancer (Dove Medical Press)|March 20, 2026
Recent Advances in Antibody-Drug Conjugates and Immunotherapy Combinations for Treatment of Triple-Negative Breast CancerHuihui Chen, Wei Lu, Yunxiang Zhou, et al.Expert Opinion on Investigational Drugs|July 5, 2022
Cyclin-dependent kinase inhibition and its intersection with immunotherapy in breast cancer: more than CDK4/6 inhibitionXianan Guo, Huihui Chen, Yunxiang Zhou, et al.Frontiers in Immunology|September 25, 2020
Affective Immunology: The Crosstalk Between Microglia and Astrocytes Plays Key Role?Linglin Yang, Yunxiang Zhou, Honglei Jia, et al.Journal of Cellular and Molecular Medicine|July 14, 2020
Osteopontin as a candidate of therapeutic application for the acute brain injuryYunxiang Zhou, Yihan Yao, Lesang Sheng, et al.Oxidative Medicine and Cellular Longevity|June 21, 2022
Glymphatic System: Emerging Therapeutic Target for Neurological DiseasesXianjun Xuan, Guoyi Zhou, Caihong Chen, et al.Plos One|August 30, 2019
Changes in lipid profiles during and after (neo)adjuvant chemotherapy in women with early-stage breast cancer: A retrospective studyWei Tian, Yihan Yao, Guocai Fan, et al.Journal of Molecular Cell Biology|December 8, 2025
NOC4L coordinates neuronal and pharyngeal arch development by regulating ribosome biogenesisTujing Song, Yan Liu, Yunxiang Zhou, et al.Aging and Disease|November 10, 2025
Neoadjuvant Immunotherapy in Triple-Negative Breast Cancer: Striking Potential or Need for Caution?Panni Li, Xianan Guo, Wenhui Ruan, et al.Pageof 6